Commit To Buy Pacific Biosciences Of California At $5, Earn 36.3% Annualized

Investors eyeing a purchase of Pacific Biosciences of California ( PACB) stock, but cautious about paying the going market price of $5.83/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2014 put at the $5 strike, which has a bid at the time of this writing of 85 cents. Collecting that bid as the premium represents a 17% return against the $5 commitment, or a 36.3% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

START SLIDESHOW:
Top YieldBoost Puts of the S&P 500 »

Selling a put does not give an investor access to PACB's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $5 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless Pacific Biosciences of California Inc sees its shares fall 13.2% and the contract is exercised (resulting in a cost basis of $4.15 per share before broker commissions, subtracting the 85 cents from $5), the only upside to the put seller is from collecting that premium for the 36.3% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for Pacific Biosciences of California Inc, and highlighting in green where the $5 strike is located relative to that history:

Loading+chart++2013+TickerTech.com

The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the March 2014 put at the $5 strike for the 36.3% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Pacific Biosciences of California Inc (considering the last 250 trading day closing values as well as today's price of $5.83) to be 88%. For other put options contract ideas at the various different available expirations, visit the PACB Stock Options page of StockOptionsChannel.com.

null

If you liked this article you might like

Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers

Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers

Biotech Movers: Pacific Biosciences Shares Lower After Pricing Stock Offering

Biotech Movers: Pacific Biosciences Shares Lower After Pricing Stock Offering

Biotech Movers: Pacific Biosciences Falls After Net Loss Spikes

Biotech Movers: Pacific Biosciences Falls After Net Loss Spikes

Biotech Premarket Movers: Pacific Biosciences of California, AMAG, Global Blood Therapeutics

Biotech Premarket Movers: Pacific Biosciences of California, AMAG, Global Blood Therapeutics

Health Sector Down As Report of Industry Price Collusion Surfaces

Health Sector Down As Report of Industry Price Collusion Surfaces